125 related articles for article (PubMed ID: 11323500)
1. Interferon regulatory factor expression in human breast cancer.
Doherty GM; Boucher L; Sorenson K; Lowney J
Ann Surg; 2001 May; 233(5):623-9. PubMed ID: 11323500
[TBL] [Abstract][Full Text] [Related]
2. Interferon regulatory factor-1 and -2 expression in human melanoma specimens.
Lowney JK; Boucher LD; Swanson PE; Doherty GM
Ann Surg Oncol; 1999 Sep; 6(6):604-8. PubMed ID: 10493631
[TBL] [Abstract][Full Text] [Related]
3. The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell lines.
Yim JH; Ro SH; Lowney JK; Wu SJ; Connett J; Doherty GM
J Interferon Cytokine Res; 2003 Sep; 23(9):501-11. PubMed ID: 14565859
[TBL] [Abstract][Full Text] [Related]
4. Localization of IFN-gamma-activated Stat1 and IFN regulatory factors 1 and 2 in breast cancer cells.
Connett JM; Hunt SR; Hickerson SM; Wu SJ; Doherty GM
J Interferon Cytokine Res; 2003 Nov; 23(11):621-30. PubMed ID: 14651776
[TBL] [Abstract][Full Text] [Related]
5. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.
Bi X; Hameed M; Mirani N; Pimenta EM; Anari J; Barnes BJ
Breast Cancer Res; 2011; 13(6):R111. PubMed ID: 22053985
[TBL] [Abstract][Full Text] [Related]
6. Interferon regulatory factor 1 (IRF-1) and IRF-2 expression in breast cancer tissue microarrays.
Connett JM; Badri L; Giordano TJ; Connett WC; Doherty GM
J Interferon Cytokine Res; 2005 Oct; 25(10):587-94. PubMed ID: 16241857
[TBL] [Abstract][Full Text] [Related]
7. Interferon regulatory factor-1 expression in human uterine endometrial carcinoma.
Kuroboshi H; Okubo T; Kitaya K; Nakayama T; Daikoku N; Fushiki S; Honjo H
Gynecol Oncol; 2003 Nov; 91(2):354-8. PubMed ID: 14599866
[TBL] [Abstract][Full Text] [Related]
8. Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin.
Pizzoferrato E; Liu Y; Gambotto A; Armstrong MJ; Stang MT; Gooding WE; Alber SM; Shand SH; Watkins SC; Storkus WJ; Yim JH
Cancer Res; 2004 Nov; 64(22):8381-8. PubMed ID: 15548708
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
10. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.
Mommers EC; Leonhart AM; Falix F; Michalides R; Meijer CJ; Baak JP; Diest PJ
J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365
[TBL] [Abstract][Full Text] [Related]
11. The interferon-alpha regulation of interferon regulatory factor 1 (IRF-1) and IRF-2 has therapeutic implications in carcinoid tumors.
Zhou Y; Wang S; Gobl A; Oberg K
Ann Oncol; 2000 Jun; 11(6):707-14. PubMed ID: 10942060
[TBL] [Abstract][Full Text] [Related]
12. Nm23 protein expression in ductal in situ and invasive human breast carcinoma.
Royds JA; Stephenson TJ; Rees RC; Shorthouse AJ; Silcocks PB
J Natl Cancer Inst; 1993 May; 85(9):727-31. PubMed ID: 8386774
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of interleukin-7 in human intestinal epithelial cells.
Oshima S; Nakamura T; Namiki S; Okada E; Tsuchiya K; Okamoto R; Yamazaki M; Yokota T; Aida M; Yamaguchi Y; Kanai T; Handa H; Watanabe M
Mol Cell Biol; 2004 Jul; 24(14):6298-310. PubMed ID: 15226432
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma signaling in human retinal pigment epithelial cells mediated by STAT1, ICSBP, and IRF-1 transcription factors.
Li W; Nagineni CN; Hooks JJ; Chepelinsky AB; Egwuagu CE
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):976-82. PubMed ID: 10102295
[TBL] [Abstract][Full Text] [Related]
15. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
Nguyen H; Mustafa A; Hiscott J; Lin R
Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638
[TBL] [Abstract][Full Text] [Related]
17. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2.
Xi H; Eason DD; Ghosh D; Dovhey S; Wright KL; Blanck G
Oncogene; 1999 Oct; 18(43):5889-903. PubMed ID: 10557076
[TBL] [Abstract][Full Text] [Related]
18. LEA.135 expression: identifies low-risk patients with breast ductal carcinoma in situ.
Baltayan A; Naritoku WY; Chaiwun B; Tsao-Wei DD; Groshen S; Hern RA; Gusterson BA; Taylor CR; Imam SA
Anticancer Res; 2002; 22(5):2933-7. PubMed ID: 12530020
[TBL] [Abstract][Full Text] [Related]
19. Ectopic expression of interferon regulatory factor-1 potentiates granulocytic differentiation.
Coccia EM; Stellacci E; Valtieri M; Masella B; Feccia T; Marziali G; Hiscott J; Testa U; Peschle C; Battistini A
Biochem J; 2001 Dec; 360(Pt 2):285-94. PubMed ID: 11716756
[TBL] [Abstract][Full Text] [Related]
20. Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family.
Bovolenta C; Driggers PH; Marks MS; Medin JA; Politis AD; Vogel SN; Levy DE; Sakaguchi K; Appella E; Coligan JE
Proc Natl Acad Sci U S A; 1994 May; 91(11):5046-50. PubMed ID: 8197182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
